Literature DB >> 35234993

Erythropoietin regulates signaling pathways associated with neuroprotective events.

Cornelio-Martínez Sergio1, Castañeda-Arellano Rolando2.   

Abstract

Erythropoietin is a cytokine that binds to the Erythropoietin receptor and regulates the formation of erythroid cells during erythropoiesis in the bone marrow. However, many other organs and tissues express Erythropoietin and its receptor, such as the Nervous System, which principally regulates tissue protection. In the Central Nervous System, Erythropoietin is principally expressed by astrocytes, while neurons mainly express Erythropoietin receptors. Moreover, Erythropoietin acts as a pleiotropic molecule with neuroprotective effects, and its mechanisms of signal transduction pathways are defined, and there is a growing interest in its therapeutic potential. This review focuses on the role of Erythropoietin and its relationship with HIF1, PI3/Akt, GSK3B, JAK/STAT, and MAPKs signaling pathways that leads to cell survival after injury in the Central Nervous System. Knowledge of these signaling systems comprehensively could better guide EPO treatment to restoring different SNC alterations mediated by different insults.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Central nervous system; Erythropoietin; Erythropoietin receptor; Hypoxic Inducible factor 1; Neuroprotection; Signaling pathway

Mesh:

Substances:

Year:  2022        PMID: 35234993     DOI: 10.1007/s00221-022-06331-9

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  78 in total

1.  Tissue-specific regulation of erythropoietin production in the murine kidney, brain, and uterus.

Authors:  M Chikuma; S Masuda; T Kobayashi; M Nagao; R Sasaki
Journal:  Am J Physiol Endocrinol Metab       Date:  2000-12       Impact factor: 4.310

2.  Expression of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1 in human brain tumors and their involvement in glial proliferation in vitro.

Authors:  Simone Barbero; Adriana Bajetto; Rudy Bonavia; Corola Porcile; Patrizia Piccioli; Paolo Pirani; Jean Louis Ravetti; Gianluigi Zona; Renato Spaziante; Tullio Florio; Gennaro Schettini
Journal:  Ann N Y Acad Sci       Date:  2002-11       Impact factor: 5.691

3.  A potential role for erythropoietin in focal permanent cerebral ischemia in mice.

Authors:  M Bernaudin; H H Marti; S Roussel; D Divoux; A Nouvelot; E T MacKenzie; E Petit
Journal:  J Cereb Blood Flow Metab       Date:  1999-06       Impact factor: 6.200

Review 4.  Chemokines and their receptors in the central nervous system.

Authors:  A Bajetto; R Bonavia; S Barbero; T Florio; G Schettini
Journal:  Front Neuroendocrinol       Date:  2001-07       Impact factor: 8.606

5.  Activation of the transcription factor NF-kappaB by the erythropoietin receptor: structural requirements and biological significance.

Authors:  T Bittorf; T Büchse; T Sasse; R Jaster; J Brock
Journal:  Cell Signal       Date:  2001-09       Impact factor: 4.315

6.  Activity increase in EpoR and Epo expression by intranasal recombinant human erythropoietin (rhEpo) administration in ischemic hippocampi of adult rats.

Authors:  R Castañeda-Arellano; A I Feria-Velasco; M C Rivera-Cervantes
Journal:  Neurosci Lett       Date:  2014-09-16       Impact factor: 3.046

Review 7.  The MAPK pathway across different malignancies: a new perspective.

Authors:  Mauricio Burotto; Victoria L Chiou; Jung-Min Lee; Elise C Kohn
Journal:  Cancer       Date:  2014-06-19       Impact factor: 6.860

Review 8.  The non-haematopoietic biological effects of erythropoietin.

Authors:  Murat O Arcasoy
Journal:  Br J Haematol       Date:  2008-04       Impact factor: 6.998

Review 9.  Cellular oxygen sensing need in CNS function: physiological and pathological implications.

Authors:  Till Acker; Helmut Acker
Journal:  J Exp Biol       Date:  2004-08       Impact factor: 3.312

10.  HIF prolyl hydroxylase inhibition prior to transient focal cerebral ischaemia is neuroprotective in mice.

Authors:  Ruoli L Chen; O O Ogunshola; Karkheng K Yeoh; Anant Jani; Michalis Papadakis; Simon Nagel; Christopher J Schofield; Alastair M Buchan
Journal:  J Neurochem       Date:  2014-07-18       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.